IFMAD 2017

IFMAD has developed the reputation over many years of being the most interactive, stimulating and productive educational meeting in its field in Europe and since 2015 we are providing an even more comprehensive scientific and educational programme.

It is accredited for continuing medical education. In a friendly atmosphere difficult clinical challenges are dissected, discussed and reformulated with high ranking experts to achieve the best evidence based path to treatment in depression, anxiety and bipolar disorder. To avoid bias, our educational program is completely independent from pharmaceutical support.

IFMAD 2017 topics will include: Update on rapid acting antidepressants, Treatment adherence, Cognition in Mood Disorders, Update on treatment of Anxiety Disorders, Advances in treatment of resistant depression, Biomarkers for Mood Disorders, Long acting antipsychotics in Bipolar Disorder, Update on psychoneuroimmunology, Overlap of negative symptoms and depression, Anxiety Disorder spectrum, Brain gut interactions.


More information about IFMAD 2017 are available on